Full Coverage

MFI Stock Review: Cephalon (CEPH)

                   
istockanalyst.com
Nov 5, 2009
 
Story Timeline:  16 days

Bio and Articles Author's Website The next market session will close: Cephalon specializes in bio-pharmaceuticals that target central nervous system (CNS) disorders, pain treatments, and oncology (cancer). The final meaningful... [read full story]                    

powered by
Add Comment
Latest article on this story:

Cephalon's Upside and Downside (at Seeking Alpha)

 yahoo.com Nov 8, 2009
First article on this story:

Cephalon's Upside and Downside (at Seeking Alpha)

 yahoo.com Nov 8, 2009
Selected publications with coverage of this story:
istockanalyst.com yahoo.com
RELATED
Found 1 documents:
                   

Cephalon's Upside and Downside (at Seeking Alpha)

yahoo.com
Nov 8, 2009
 

by: Steve Alexander November 08, 2009 | about: ) specializes in bio-pharmaceuticals that target central nervous system disorders, pain treatments, and oncology (cancer). The final meaningful drug is Treanda, a treatment for...

powered by